
    
      Patients are randomized to one of four treatment groups. Intravenous foscarnet is
      administered for 4 days. Patients receive one of three doses of magnesium sulfate or placebo
      in normal saline according to one of four schedules. Sequence of doses will differ for each
      group.
    
  